19 June 2025
Latham & Watkins Advises Caris Life Sciences on IPO
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | Not stated | New York |
| Alison Haggerty Lead | Latham & Watkins LLP | Partner | Not stated | New York |
| Samer Zabaneh Lead | Latham & Watkins LLP | Partner | Not stated | Austin |
| Sandy Kugbei | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Jie Lin Nai | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Akina Newbraugh | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Radley Gillis | Latham & Watkins LLP | Associate | Not stated | Not stated |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Issue size
- Client
- Caris Life SciencesIssuer
- Counterparties
- Not stated